70 results on '"Luetgehetmann M"'
Search Results
2. New findings in HCV genotype distribution in selected West European, Russian and Israeli regions
3. Animal models for the study of HBV replication and its variants
4. CONFOCAL LASER-SCANNING MICROSCOPY ANALYSIS of in VIVO FORMED HETEROTOPIC LIVER NEO-TISSUE AFTER MATRIX-BASED HEPATOCYTE TRANSPLANTATION: 44
5. Verlauf von HEV-Virämie und anti-HEV IgM/IgG-Antwort bei 27 immunkompetenten Blutspendern
6. Clinical impact, morbidity and mortality of Hepatitis E at tertiary referral centres in central Europe
7. Characterization of the HEV-specific CD8+ T-cell response in acute and chronic hepatitis E virus infection
8. Comparison of HDV mono-infection with genotype 1 and 3 in CRPISPR/Cas generated humanized NTCP mice and human liver chimeric mice
9. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations
10. HBV infection alters the transcriptional regulation of FXR-dependent microRNAs
11. SAT-430 - Characterization of the HEV-specific CD8+ T-cell response in acute and chronic hepatitis E virus infection
12. SAT-370 - The protein complex structural maintenance of chromosomes reappears after interferon alpha treatment in hepatitis B virus infected humanized mice but its presence does not hinder viral rebound
13. SAT-329 - Clinical impact, morbidity and mortality of Hepatitis E at tertiary referral centres in central Europe
14. P0596 : Association of hepatitis E virus and cryoglobulinemia
15. O012 : Hepatitis delta virus can survive liver regeneration and is amplified through human cell division both in vitro and in vivo
16. SAT-175 - Comparison of HDV mono-infection with genotype 1 and 3 in CRPISPR/Cas generated humanized NTCP mice and human liver chimeric mice
17. SAT-176 - Serum HBV pgRNA can serve as clinical marker for cccDNA activity in patients with HBV mono and HBV/HDV co-infection
18. SAT-179 - Hepatitis B virus infection alters the transcriptional regulation of FXR-dependent microRNAs
19. SAT-421 - Impact of sex and apolipoproteins on macrophage activation and Entamoeba histolytica induced liver damage
20. PS-110 - Blood-borne HEV transmission: first experience with global HEV screening at a tertiary center
21. P217 PROMOTER POLYMORPHISM OF HEME OXYGENASE-1 BIASES ITS POTENCY TO SUPPRESS HCV REPLICATION BUT DOES NOT IMPACT ITS HEPATOPROTECTIVE EFFECTS
22. FRI-219 - Prevention of Viral Spread, Viremia Reduction and HBsAg Clearance in Hepatitis B and D Coinfected Humanized Mice by a Human Neutralizing Monoclonal Antibody
23. THU-190 - Single Cell Analyses Demonstrate No Up-Regulation of Human Innate Genes in HDV Mono-Infected Human Hepatocytes
24. THU-192 - Innate Immune Sensing of Hepatitis B Virus and Response to Interferon Stimulation are Mostly Elicited in Non HBV Producing Human Hepatocytes in Vivo
25. PS032 - Immunotherapy using T Cells Redirected against HBV Results in Reduced Viral Loads and Enhanced Immune Responses in Humanized Mice
26. P0676 : Clearance of persistent hepatitis c virus infection using a monoclonal antibody specific for tight junction protein claudin-1
27. P0558 : HBV infection is not affected by the induction of FXR activity but may limit the activity of FXR agonists in humanized mice
28. P0530 : Myrcludex-B inhibits establishment of HDV super-infection in HBV infected mice and reduces HDV viremia in stably HBV/HDV co-infected mice
29. 69 VIRION HALF-LIFE IN CHRONIC HEPATITIS B INFECTION IS STRONGLY CORRELATED WITH VIRAL LOAD
30. 658 LOWER HEPATITIS B VIRUS PRODUCTIVITY IN THE HBeAg-NEGATIVE PHASE IS NOT DUE TO THE EMERGENCE OF VIRAL MUTATIONS WITHIN REGULATORY REGIONS
31. P875 FIRST CASE REPORT OF A PATIENT WITH FIBROSING CHOLESTATIC HEPATITIS C AFTER LIVER TRANSPLANTATION TREATED WITH SOFOSBUVIR AND SIMEPREVIR
32. P886 RELEVANCE OF CHRONIC HEPATITIS E IN LIVER TRANSPLANT RECIPIENTS: A REAL-LIFE-SETTING
33. O102 PROLIFERATION OF HBV-INFECTED HUMAN HEPATOCYTES IN HUMANIZED MICE PROMOTES THE OCCURRENCE OF VIRAL INTEGRATIONS WITHIN THE HOST GENOME
34. 1161 INDUCTION OF HEME OXYGENASE-1 IN HUMAN HEPATOCYTES PROVIDES HEPATOPROTECTIVE EFFECTS AND SUPPRESSES HCV REPLICATION IN CHIMERIC uPA/SCID MICE
35. 390 NEW INTRAHEPATIC qPCR ASSAY DISSECTS THE DIFFERENT ANTIVIRAL EFFECTS INDUCED BY INTERFERON OR ENTECAVIR IN HDV INFECTED HUMAN-CHIMERIC uPA-SCID MICE
36. 127 PROLIFERATION OF HEPATITIS B VIRUS INFECTED HUMAN HEPATOCYTES INDUCES SUPPRESSION OF VIRAL REPLICATION AND RAPID cccDNA DECREASE IN HUMANIZED MICE
37. 124 HEPATITIS DELTA INFECTION IN HUMANIZED UPA/SCID-MICE LEADS TO PRONOUNCED INDUCTION OF HUMAN-SPECIFIC INNATE IMMUNE RESPONSES AND CYTOKINE EXPRESSION IN COMPARISON TO HBV MONO-INFECTION
38. 456 PRETREATMENT OF HUMANIZED UPA/SCID MICE WITH INTERFERON ALPHA STRONGLY INHIBITS THE ESTABLISHMENT OF HEPATITIS B VIRUS INFECTION
39. 42 PEGYLATED-INTERFERON-ALPHA ALONE OR IN COMBINATION WITH ENTECAVIR RESTORES ISG RESPONSIVENESS AND REDUCES INTRAHEPATIC VIRAL LOADS AND ANTIGENEMIA IN HEPATITIS B VIRUS INFECTED HUMANIZED MICE
40. 515 LENTIVIRAL ‘GENE ONTOLOGY’ (LEGO) VECTORS ENABLE HIGHLY EFFICIENT EX VIVO TRANSDUCTION OF HEPATOCYTES SUITABLE FOR CELL TRANSPLANTATION
41. 1020 SAFETY AND EFFICACY OF ENTECAVIR AND TENOFOVIR COMBINATION-THERAPY IN HEPATITIS B PATIENTS WITH PREVIOUS TREATMENT FAILURES. AN INTERNATIONAL MULTICENTER COHORT STUDY
42. 610 STRONG IN VIVO ANTIVIRAL EFFICACY OF A NEW L-DEOXYCYTIDINE DERIVATE IN HEPATITIS B VIRUS INFECTED HUMAN HEPATOCYTES REPOPULATING THE LIVER OF UPA/SCID MICE
43. 109 HEPATITIS B VIRUS RESTRAINS ACTIVATION OF SPECIFIC INTERFERON RESPONSIVE GENES IN HUMAN HEPATOCYTES REPOPULATING THE LIVER OF UPA/SCID MICE
44. 922 RESCUE THERAPY WITH COMBINATION OF ENTECAVIR AND TENOFOVIR IN PATIENTS WITH CHRONIC HBV, ADVANCED FIBROSIS AND MULTIPLE PREVIOUS TREATMENT FAILURES IS SAFE AND HIGHLY EFFICIENT
45. 367 CYTOKINE EXPRESSION PROFILES IN THE LIVER OF INDIVIDUALS CHRONICALLY INFECTED WITH HEPATITIS B VIRUS DO NOT CORRELATE WITH VIROLOGICAL PARAMETERS
46. 97 GROWTH OF HEPADNAVIRUS INFECTED HEPATOCYTES STRONGLY REDUCES VIRION PRODUCTIVITY AND CCCDNA LOADS IN UPA MICE
47. 77 VIRAL LOADS CORRELATE WITH MILD SUPPRESSION OF THE TOLL-LIKE RECEPTOR SIGNALING IN THE LIVER OF CHRONIC HEPATITIS B PATIENTS
48. O.184 In vivo inhibition of HBV infection by acylated preS peptides in the urokinase-type plasminogen activator (UPA) mouse model
49. 35 In vivo inhibition of HBV infection by acylated pres peptides in the urokinase-type plasminogen activator (UPA) mouse model
50. IN VITRO ENGINEERING OF A FUNCTIONAL HUMAN LIVER TISSUE FOR TRANSPLANTATION.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.